Andlauer Healthcare Group Inc. (ANDHF)

USD 28.49

(0.0%)

EBITDA Summary of Andlauer Healthcare Group Inc.

Andlauer Healthcare Group Inc.'s latest annual EBITDA in 2023 was 133.75 Million CAD , down -6.06% from previous year.
Andlauer Healthcare Group Inc.'s latest quarterly EBITDA in 2024 Q2 was 39.77 Million CAD , down -29.56% from previous quarter.
Andlauer Healthcare Group Inc. reported an annual EBITDA of 175.06 Million CAD in 2022, up 50.14% from previous year.
Andlauer Healthcare Group Inc. reported an annual EBITDA of 116.41 Million CAD in 2021, up 47.44% from previous year.
Andlauer Healthcare Group Inc. reported a quarterly EBITDA of 39.58 Million CAD for 2024 Q1, down -12.75% from previous quarter.
Andlauer Healthcare Group Inc. reported a quarterly EBITDA of 38.97 Million CAD for 2023 Q3, down -1.12% from previous quarter.

Annual EBITDA Chart of Andlauer Healthcare Group Inc. (2023 - 2016)

Historical Annual EBITDA of Andlauer Healthcare Group Inc. (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	133.75 Million CAD	-6.06%
2022	175.06 Million CAD	50.14%
2021	116.41 Million CAD	47.44%
2020	79.19 Million CAD	11.69%
2019	70.69 Million CAD	9.85%
2018	64.35 Million CAD	11.69%
2017	57.62 Million CAD	9.96%
2016	52.4 Million CAD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	39.77 Million CAD	-29.56%
2024 Q1	39.58 Million CAD	-12.75%
2023 Q3	38.97 Million CAD	-1.12%
2023 Q1	40.45 Million CAD	-9.35%
2023 Q2	39.41 Million CAD	-2.56%
2023 Q4	45.36 Million CAD	16.4%
2023 FY	- CAD	-6.06%
2022 Q1	39.65 Million CAD	12.86%
2022 Q4	44.62 Million CAD	0.71%
2022 Q3	44.3 Million CAD	-4.13%
2022 Q2	46.21 Million CAD	16.55%
2022 FY	- CAD	50.14%
2021 Q4	35.13 Million CAD	29.91%
2021 Q3	27.04 Million CAD	-7.17%
2021 Q1	25.1 Million CAD	68.03%
2021 Q2	29.13 Million CAD	16.06%
2021 FY	- CAD	47.44%
2020 Q1	18.79 Million CAD	50.36%
2020 Q2	17.97 Million CAD	-4.36%
2020 Q3	19.28 Million CAD	7.25%
2020 FY	- CAD	11.69%
2020 Q4	14.94 Million CAD	-22.51%
2019 Q4	12.5 Million CAD	-30.11%
2019 FY	- CAD	9.85%
2019 Q3	17.88 Million CAD	0.76%
2019 Q2	17.75 Million CAD	3.16%
2019 Q1	17.2 Million CAD	71.74%
2018 Q3	15.81 Million CAD	0.0%
2018 Q4	10.02 Million CAD	-36.65%
2018 FY	- CAD	11.69%
2017 FY	- CAD	9.96%
2016 FY	- CAD	0.0%

Peer EBITDA Comparison of Andlauer Healthcare Group Inc.

Name	EBITDA	EBITDA Difference
Addentax Group Corp.	883.94 Thousand USD	-15031.344%
Grindrod Limited	62.2 Million USD	-115.028%
Janel Corporation	5.63 Million USD	-2275.702%
Scoobeez Global, Inc.	1.29 Million USD	-10206.136%
Stonepath Group Inc.	2.51 Million USD	-5224.552%
Unique Logistics International, Inc.	-6.53 Million USD	2147.22%